Regeneron Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Regeneron Pharmaceuticals patents 704 in total
| Status | Patent |
|---|---|
Application | Utility: HIGH AFFINITY ANTIBODIES TO HUMAN IL-6 RECEPTOR Filling date: 12 Sep 2025 Issue date: 14 Jan 2021 |
Grant | Utility: Use of a VEGF antagonist to treat angiogenic eye disorders Filling date: 12 Sep 2025 Issue date: 12 Jan 2021 |
Application | Utility: Treatment Of Decreased Bone Mineral Density With Zinc And Ring Finger 3 (ZNRF3) Inhibitors Filling date: 12 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: Genome-Based Methods For Reducing Cardiovascular Risk Filling date: 12 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-33 ANTAGONIST Filling date: 12 Sep 2025 Issue date: 7 Jan 2021 |
Grant | Utility: Genetically modified mouse whose genome comprises a humanized CD274 gene Filling date: 12 Sep 2025 Issue date: 5 Jan 2021 |
Grant | Utility: Non-human animals that make single domain binding proteins Filling date: 12 Sep 2025 Issue date: 5 Jan 2021 |
Application | Utility: MODELING TDP-43 PROTEINOPATHY Filling date: 12 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: METHOD OF DIAGNOSIS AND TREATMENT OF RHEUMATOID ARTHRITIS Filling date: 12 Sep 2025 Issue date: 31 Dec 2020 |
Grant | Design: Packaging Filling date: 12 Sep 2025 Issue date: 29 Dec 2020 |
Grant | Utility: High affinity human antibodies to human angiopoietin-2 Filling date: 12 Sep 2025 Issue date: 29 Dec 2020 |
Application | Utility: B4GALT1 Variants And Uses Thereof Filling date: 12 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND PSMA AND CD3 IN COMBINATION WITH 4-1BB CO-STIMULATION Filling date: 12 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND MUC16 AND CD3 IN COMBINATION WITH 4-1BB CO-STIMULATION Filling date: 12 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING PAIN IN SUBJECTS WITH RHEUMATOID ARTHRITIS Filling date: 12 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR THERAPEUTIC PROTEIN DELIVERY Filling date: 12 Sep 2025 Issue date: 24 Dec 2020 |
Grant | Utility: Genetically modified major histocompatibility complex mice Filling date: 12 Sep 2025 Issue date: 22 Dec 2020 |
Grant | Utility: Syringe systems, piston seal systems, stopper systems, and methods of use and assembly Filling date: 12 Sep 2025 Issue date: 22 Dec 2020 |
Application | Utility: ANTI-PCRV ANTIBODIES THAT BIND PCRV, COMPOSITIONS COMPRISING ANTI-PCRV ANTIBODIES, AND METHODS OF USE THEREOF Filling date: 12 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: METHODS FOR IDENTIFYING AND QUANTITATING HOST CELL PROTEIN Filling date: 12 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: ANGPTL8 ASSAY AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 17 Dec 2020 |
Grant | Utility: Bispecific antigen-binding molecules that bind a staphylococcus target antigen and a complement component and uses thereof Filling date: 12 Sep 2025 Issue date: 15 Dec 2020 |
Grant | Utility: Rodents having a humanized TMPRSS gene Filling date: 12 Sep 2025 Issue date: 15 Dec 2020 |
Application | Utility: NON-HUMAN ANIMALS COMPRISING A HUMANIZED ALBUMIN LOCUS Filling date: 12 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: NON-HUMAN ANIMALS COMPRISING A HUMANIZED TTR LOCUS WITH A BETA-SLIP MUTATION AND METHODS OF USE Filling date: 12 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: Maytansinoid Derivatives, Conjugates Thereof, and Methods of Use Filling date: 12 Sep 2025 Issue date: 10 Dec 2020 |
Grant | Utility: Formulations of VEG antagonist fusion proteins and method of manufacturing them Filling date: 12 Sep 2025 Issue date: 8 Dec 2020 |
Grant | Utility: Use of a VEGF antagonist to treat angiogenic eye disorders Filling date: 12 Sep 2025 Issue date: 8 Dec 2020 |
Application | Utility: VL ANTIGEN BINDING PROTEINS EXHIBITING DISTINCT BINDING CHARACTERISTICS Filling date: 12 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: Anti-STEAP2 Antibodies, Antibody-Drug Conjugates, and Bispecific Antigen-Binding Molecules that Bind STEAP2 and CD3, and Uses Thereof Filling date: 12 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: GENETICALLY MODIFIED MAJOR HISTOCOMPATIBILITY COMPLEX MICE Filling date: 12 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: GENETICALLY MODIFIED MAJOR HISTOCOMPATIBILITY COMPLEX ANIMALS Filling date: 12 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: HUMAN ANTIBODIES TO INFLUENZA HEMAGGLUTININ Filling date: 12 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: METHODS FOR TREATING HYPERLIPIDEMIA WITH AN ANGPTL8 INHIBITOR AND AN ANGPTL3 INHIBITOR Filling date: 12 Sep 2025 Issue date: 3 Dec 2020 |
Grant | Design: Auto-injector Filling date: 12 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Biomarkers related to interleukin-33 (IL-33)-mediated diseases and uses thereof Filling date: 12 Sep 2025 Issue date: 1 Dec 2020 |
Application | Utility: METHOD FOR GENERATING HIGH AFFINITY ANTIBODIES Filling date: 12 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: NON-HUMAN ANIMALS HAVING A HEXANUCLEOTIDE REPEAT EXPANSION IN A C9ORF72 LOCUS Filling date: 12 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: CHARACTERIZATION OF DOMAIN-SPECIFIC CHARGE VARIANTS OF ANTIBODIES Filling date: 12 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: Synaptojanin 2 (SYNJ2) Variants And Uses Thereof Filling date: 12 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: STABILIZED FORMULATIONS CONTAINING ANTI-ANGPTL3 ANTIBODIES Filling date: 12 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: RIFAMYCIN ANALOGS AND ANTIBODY-DRUG CONJUGATES THEREOF Filling date: 12 Sep 2025 Issue date: 26 Nov 2020 |
Grant | Utility: Anti-CTLA-4 antibodies and uses thereof Filling date: 12 Sep 2025 Issue date: 24 Nov 2020 |
Application | Utility: Competitive Ligand Binding Assays Filling date: 12 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: HSD17B13 VARIANTS AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 12 Nov 2020 |
Application | Utility: ROTATABLE SURGICAL TABLE Filling date: 12 Sep 2025 Issue date: 12 Nov 2020 |
Grant | Utility: Use of a VEGF antagonist to treat angiogenic eye disorders Filling date: 12 Sep 2025 Issue date: 10 Nov 2020 |
Application | Utility: RADIOLABELED ANTI-PD-L1 ANTIBODIES FOR IMMUNO-PET IMAGING Filling date: 12 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: COMBINATION OF IL-4/IL-13 PATHWAY INHIBITORS AND PLASMA CELL ABLATION FOR TREATING ALLERGY Filling date: 12 Sep 2025 Issue date: 5 Nov 2020 |
Grant | Utility: Non-human animals having an engineered immunoglobulin .LAMBDA. light chain locus Filling date: 12 Sep 2025 Issue date: 3 Nov 2020 |
Showing 300 to 350 of 704 patents.